Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00784719 · ClinicalTrials.gov registry record · Phase 1
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 327
- Enrollment target
NCT00784719: Completed Phase 1 study, sponsored by Pfizer.
NCT00784719 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 327 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (445% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00784719, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 327 participants
- Enrollment target
Study Summary
A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.
Primary Outcome
An AE is defined as any untoward medical occurrence in a participant or clinical investigation participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. Systemic AEs are the events which are not localized but occur throughout the systemic circulation.
Interventions
- DRUG Cyclosporine
- DRUG CP-690,550
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
What the finished NCT00784719 record still lists
NCT00784719 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (445% higher).
The record links to 0 conditions, and to 2 interventions - of which Cyclosporine is the first listed.
NCT00784719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00784719 about?
NCT00784719 is a clinical study titled "A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.". A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.
What is the current status of trial NCT00784719?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 327 participants. The study started on 2008-11. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00784719?
The interventions under investigation include: Cyclosporine (DRUG), CP-690,550 (DRUG).
Who is sponsoring clinical trial NCT00784719?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00784719's enrollment target sits among peer trials
327 111th of 2000 higher than 1,890 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia